Shire paid $56.5 million to resolve civil allegations concerning unsupported Adderall XR superiority and outcome claims and misleading Vyvanse abuse-liability statements. The resolved claims were allegations only, with no determination of liability.
Shire also allegedly marketed Adderall XR based on unsupported claims that Adderall XR would prevent poor academic performance, loss of employment, criminal behavior, traffic accidents and sexually transmitted disease.
Shire paid $56.5 million to resolve civil allegations concerning unsupported Adderall XR superiority and outcome claims and misleading Vyvanse abuse-liability statements. The resolved claims were allegations only, with no determination of liability.